Enlarged Prostate Therapy Options
Benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate, affects more than 50% of men over the age of 60. This non-cancerous condition causes the prostate gland to enlarge, pressing against the urethra and leading to urinary symptoms such as frequent urination, weak stream, nocturia, and incomplete bladder emptying. While lifestyle changes like reducing caffeine intake and bladder training can provide initial relief, therapy options range from medications to advanced surgical interventions. Consulting a urologist is essential to tailor treatment to symptom severity and overall health.
Medication Therapies
The first-line treatment for BPH often involves medications, which effectively manage symptoms in many patients. Alpha-blockers, such as tamsulosin (Flomax) and alfuzosin (Uroxatral), relax the smooth muscles in the prostate and bladder neck, improving urine flow within days. These drugs reduce symptoms by 50-70% in responsive patients but may cause side effects like dizziness or retrograde ejaculation. For larger prostates, 5-alpha reductase inhibitors like finasteride (Proscar) or dutasteride (Avodart) block the conversion of testosterone to dihydrotestosterone, shrinking the prostate by up to 25% over 6-12 months. Combination therapy, pairing an alpha-blocker with a 5-alpha reductase inhibitor, offers superior long-term symptom control, as shown in the MTOPS study. Phosphodiesterase-5 inhibitors, such as tadalafil (Cialis), also show promise for men with both BPH and erectile dysfunction by relaxing prostate tissues.
Minimally Invasive Procedures
When medications prove insufficient, minimally invasive therapies provide outpatient alternatives with quicker recovery than surgery. Transurethral microwave thermotherapy (TUMT) uses microwave energy to heat and destroy excess prostate tissue, alleviating obstruction in 70-80% of cases. Transurethral needle ablation (TUNA) employs radiofrequency energy via needles inserted into the prostate, offering similar efficacy with minimal bleeding risk. Newer options like UroLift implant a small device to hold prostate lobes apart, preserving sexual function and avoiding tissue removal—ideal for smaller prostates. Water vapor thermal therapy (Rezūm) injects steam to shrink tissue, with studies reporting symptom improvement lasting up to five years and low retreatment rates.
Surgical Interventions
For severe cases or when other therapies fail, surgical options deliver definitive relief. Transurethral resection of the prostate (TURP), the gold standard, removes obstructing tissue via the urethra, achieving 80-90% symptom resolution but with risks like dry ejaculation. Laser therapies, including photoselective vaporization (PVP or GreenLight) and holmium laser enucleation (HoLEP), offer precise tissue ablation with less bleeding, suitable for larger prostates. Open or robotic simple prostatectomy is reserved for very enlarged glands exceeding 80-100 grams.
In conclusion, enlarged prostate therapy options have evolved significantly, from oral medications for mild symptoms to innovative minimally invasive techniques and robust surgeries for advanced BPH. Early intervention prevents complications like urinary retention or kidney damage. Patients should weigh benefits, risks, and lifestyle impacts with their healthcare provider to select the most appropriate path forward, ensuring improved quality of life and urinary health.